Questcor Pharmaceuticals Inc (QCOR) financial statements (2021 and earlier)

Company profile

Business Address 1300 NORTH KELLOGG DRIVE
ANAHEIM, CA 92807
State of Incorp. CA
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments245155
Cash and cash equivalents17681
Short-term investments6975
Restricted cash and investments25 
Receivables8761
Inventory, net of allowances, customer advances and progress billings1610
Inventory1610
Prepaid expense and other current assets5
Other undisclosed current assets236
Total current assets:397237
Noncurrent Assets
Property, plant and equipment322
Intangible assets, net (including goodwill)511
Goodwill20 
Intangible assets, net (excluding goodwill)301
Deposits noncurrent assets00
Restricted cash and investments50 
Other undisclosed noncurrent assets20712
Total noncurrent assets:34015
TOTAL ASSETS:736252
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3442
Accounts payable1413
Employee-related liabilities1621
Taxes payable47
Debt2 
Other undisclosed current liabilities12549
Total current liabilities:16190
Noncurrent Liabilities
Long-term debt and lease obligation14 
Long-term debt, excluding current maturities14 
Liabilities, other than long-term debt30
Other liabilities30
Other undisclosed noncurrent liabilities159 
Total noncurrent liabilities:1760
Total liabilities:33791
Stockholders' equity
Stockholders' equity attributable to parent399162
Common stock3016
Accumulated other comprehensive income (loss)(3)0
Retained earnings372146
Total stockholders' equity:399162
TOTAL LIABILITIES AND EQUITY:736252

Income statement (P&L) ($ in millions)

12/31/2013
12/31/2012
Revenues
(Revenue, Net)
799509
Cost of revenue
(Cost of Goods and Services Sold)
(74)(29)
Gross profit:725481
Operating expenses(285)(184)
Operating income:440297
Nonoperating income (expense)
(Foreign Currency Transaction loss, before Tax)
(1) 
Other undisclosed income from continuing operations before equity method investments, income taxes01
Income from continuing operations before income taxes:440297
Income tax expense(147)(100)
Net income available to common stockholders, diluted:293198

Comprehensive Income ($ in millions)

12/31/2013
12/31/2012
Net income:293198
Comprehensive income:293198
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(3)0
Comprehensive income, net of tax, attributable to parent:289198

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: